SOURCE: Novo Nordisk A/S

August 15, 2008 02:32 ET

Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - August 15, 2008) - Novo Nordisk A/S - Share repurchase programme

As part of the execution of Novo Nordisk's current DKK 17.5 billion share repurchase programme expected to be finalised before the end of 2009, a repurchase programme is initiated today in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003 (Safe Harbour regulation).

For that purpose Novo Nordisk has appointed J. P. Morgan Securities Ltd. as lead manager to independently and without influence from Novo Nordisk execute the programme. The purpose of the programme is reduction of the company's share capital. Under the agreement, J. P. Morgan Securities Ltd. will repurchase shares on behalf of Novo Nordisk for an amount of up to DKK 1.7 billion during the trading period starting today and ending on 19 December 2008. A maximum of 177,940 shares can be bought during one single trading day, equal to 15% of the average daily trading volume of Novo Nordisk B shares on the OMX Nordic Exchange Copenhagen during the month of July 2008, and a maximum of 16,192,540 shares in total can be bought during the trading period. At least once every seven trading days, Novo Nordisk will issue an announcement in respect of the transactions made under the repurchase programme.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,300 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Further information:

Media:                 Investors:

Elin K Hansen          Mads Veggerby Lausten
Tel: (+45) 4442 3450   Tel: (+45) 4443 7919
ekh@novonordisk.com    mlau@novonordisk.com

                       Hans Rommer
                       Tel: (+45) 4442 4765
                       hrmm@novonordisk.com
In North America:
Sean Clements
Tel: (+1) 609 514 8316
secl@novonordisk.com

Company Announcement no 52 / 2008

Copyright © Hugin AS 2008. All rights reserved.

Contact Information